中外女性健康研究
中外女性健康研究
중외녀성건강연구
Women's Health Research
2015年
4期
210-210,231
,共2页
厄贝沙坦氢氯噻嗪复方片%厄贝沙坦片%氢氯噻嗪片%降压疗效对比
阨貝沙坦氫氯噻嗪複方片%阨貝沙坦片%氫氯噻嗪片%降壓療效對比
액패사탄경록새진복방편%액패사탄편%경록새진편%강압료효대비
Irbesartan hydrochlorothiazide compound tablets%Irbesartan,hydrochlorothiazide%Antihypertensive effect
目的：探讨厄贝沙坦氢氯噻嗪复方片（安博诺）与厄贝沙坦、氢氯噻嗪片对高血压的治疗疗效对比。方法：将郫县三道堰镇农村高血压病患者80例分为A组口服厄贝沙坦氢氯噻嗪复方片（安博诺）1片/qd 40例，B组口服厄贝沙坦片(苏适)0.15/qd，氢氯噻嗪片12.5mg /qd 40例两组，进行治疗追踪。结果：A组患者血压控制率为79.6%，B组患者血压控制率为70.8%，结论：厄贝沙坦氢氯噻嗪复方片（安博诺）与厄贝沙坦(苏适)、氢氯噻嗪片对高血压的治疗疗效相当，无统计学差异。
目的：探討阨貝沙坦氫氯噻嗪複方片（安博諾）與阨貝沙坦、氫氯噻嗪片對高血壓的治療療效對比。方法：將郫縣三道堰鎮農村高血壓病患者80例分為A組口服阨貝沙坦氫氯噻嗪複方片（安博諾）1片/qd 40例，B組口服阨貝沙坦片(囌適)0.15/qd，氫氯噻嗪片12.5mg /qd 40例兩組，進行治療追蹤。結果：A組患者血壓控製率為79.6%，B組患者血壓控製率為70.8%，結論：阨貝沙坦氫氯噻嗪複方片（安博諾）與阨貝沙坦(囌適)、氫氯噻嗪片對高血壓的治療療效相噹，無統計學差異。
목적：탐토액패사탄경록새진복방편（안박낙）여액패사탄、경록새진편대고혈압적치료료효대비。방법：장비현삼도언진농촌고혈압병환자80례분위A조구복액패사탄경록새진복방편（안박낙）1편/qd 40례，B조구복액패사탄편(소괄)0.15/qd，경록새진편12.5mg /qd 40례량조，진행치료추종。결과：A조환자혈압공제솔위79.6%，B조환자혈압공제솔위70.8%，결론：액패사탄경록새진복방편（안박낙）여액패사탄(소괄)、경록새진편대고혈압적치료료효상당，무통계학차이。
Objective:To evaluate the treatment efficacy of irbesartan hydrochlorothiazide compound tablets and irbesartan combining hydrochlorothiazide on hypertension. Methods: 80 cases of patients with hypertension were divided into A group (40 cases) using irbesartan hydrochlorothiazide compound tablets 1 piece/qd and B group (40 cases) using irbesartan 0.15/qd and hydrochlorothiazide 12.5mg/qd, the curative effect were compared in two groups. Results:The control rate of blood pressure was 79.6%in A group and 70.8%in B group. Conclusion:There is no statistical difference of the treatment efficacy between two groups.
